Intracranial Activity of Encorafenib and Binimetinib Followed by Radiotherapy in Patients with Brafmutated Melanoma and Brain Metastasis: Preliminary Results of the GEM1802 PHASE II Clinical Trial

Detalle

Iván Márquez-Rodas, Ana Arance, Miguel Ángel Berciano, Roberto Díaz Beveridge, María del Carmen Álamo, Almudena García, María González-Cao, Joana Vidal, Teresa Puértolas, Ainara Soria, Carlos Aguado, Pedro Sánchez Mauriño, Izaskun Valduvieco, Raquel Delgado, Antonio Conde, Palmira Foro, Pedro José Prada, Enrique Puertas, Ana Álvarez González, Alfonso Berrocal. Intracranial Activity of Encorafenib and Binimetinib Followed by Radiotherapy in Patients with Brafmutated Melanoma and Brain Metastasis: Preliminary Results of the GEM1802 PHASE II Clinical Trial. ESMO congress 2021

Contenidos
relacionados